Working Hard to Sell Ventilators Not Wanted by U.S.: Philips CEO

The transcript discusses Philips' 2021 growth guidance, highlighting the impact of COVID-19 on healthcare trends and the company's strategic positioning. It addresses the resurgence of COVID-19 in Europe and its effect on revenue, particularly in elective procedures. The cancellation of a large US ventilator order is examined, along with Philips' efforts to manage inventory and find new buyers. The discussion concludes with an assessment of global health preparedness for a second wave of COVID-19, emphasizing the importance of cloud technology and telehealth in future healthcare solutions.

What factors are influencing the guidance for low single-digit growth in 2021?

Evaluate responses using AI:

OFF

How is the demand for acute care equipment expected to change in the coming year?

Evaluate responses using AI:

OFF

What is the expected growth rate for Phillips from 2022 onwards?

Evaluate responses using AI:

OFF

What challenges are being faced in the diagnosis and treatment segment due to COVID-19?

Evaluate responses using AI:

OFF

What impact did the cancellation of ventilator orders have on the company?

Evaluate responses using AI:

OFF

How are governments better prepared for the second wave of COVID-19 compared to the first half of the year?

Evaluate responses using AI:

OFF

What strategies are being implemented to leverage cloud technology in healthcare?

Evaluate responses using AI:

OFF